In 1985 was created J.P. Morgan Securities Inc., which is appeared as VC. The main department of described VC is located in the New York. The company was established in North America in United States.
The top amount of exits for fund were in 2010. The real fund results show that this VC is 16 percentage points less often commits exit comparing to other companies. This J.P. Morgan Securities Inc. works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually. When the investment is from J.P. Morgan Securities Inc. the average startup value is more than 1 billion dollars. Deals in the range of 50 - 100 millions dollars are the general things for fund. The top activity for fund was in 2007.
Besides them, we counted 1 critical employee of this fund in our database.
Among the most popular portfolio startups of the fund, we may highlight LivingSocial, Legendary Entertainment, Gogo. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. If startup sums 3 of the founder, the chance for it to be financed is low. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Health Care, Manufacturing.
The typical case for the fund is to invest in rounds with 6 participants. Despite the J.P. Morgan Securities Inc., startups are often financed by JPMorgan Partners (JPMP), Sofinnova Investments, Johnson & Johnson Development Corporation. The meaningful sponsors for the fund in investment in the same round are Goldman Sachs, U.S. Venture Partners (USVP), Morgan Stanley. In the next rounds fund is usually obtained by U.S. Venture Partners (USVP), Venrock, Valor Equity Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Ascendant BioCapital | Delaware, United States, Wilmington |
| Beiming Konggu | Beijing, China, Shijingshan |
| DENSO Ventures | Awaji, Hyogo Prefecture, Japan |
| DLE Capital | Chiyoda, Japan |
| Kaipan Assets | China, Shanghai |
| LVC | - |
| Moelis Capital Partners | New York, New York, United States |
| MRTNZ Ventures | Arizona, Scottsdale, United States |
| Muskegon Angels | Michigan, Spring Lake, United States |
| Outpoint Capital Management | New York, New York, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Dafiti | $45M | 21 Aug 2012 | São Paulo | ||
Peer39 | $10M | 27 May 2009 | New York, United States | ||
PowerVision | $20M | 31 Dec 2007 | California, United States | ||
Peer39 | $8M | 01 Sep 2007 | New York, United States | ||
| $30M | 30 Aug 2007 | Sunnyvale, California, United States | |||
Neoconix | $16M | 01 Jul 2007 | San Jose, California, United States | ||
Biolex Therapeutics | $30M | 24 May 2007 | North Carolina, United States | ||
Phenomix | $55M | 08 Mar 2007 | San Diego, California, United States | ||
CXignited | $35M | 26 May 2006 | New York, New York, United States |
– J.P. Morgan has made a strategic investment in Zanbato
– The investment marks the first step in further aligning Zanbato’s ZX platform with its membership through equity participation
– Zanbato’s ZX platform is a fully-integrated, end-to-end solution for private companies and their investors to access the secondary market
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Dafiti | $45M | 21 Aug 2012 | São Paulo | ||
Peer39 | $10M | 27 May 2009 | New York, United States | ||
PowerVision | $20M | 31 Dec 2007 | California, United States | ||
Peer39 | $8M | 01 Sep 2007 | New York, United States | ||
| $30M | 30 Aug 2007 | Sunnyvale, California, United States | |||
Neoconix | $16M | 01 Jul 2007 | San Jose, California, United States | ||
Biolex Therapeutics | $30M | 24 May 2007 | North Carolina, United States | ||
Phenomix | $55M | 08 Mar 2007 | San Diego, California, United States | ||
CXignited | $35M | 26 May 2006 | New York, New York, United States |
